Global Opioid-Induced Constipation Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Opioid-Induced Constipation market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Opioid-Induced Constipation market are covered in Chapter 9:
Daiichi Sankyo
C.B. Fleet
Daewoong
Valeant Pharmaceuticals International
Johnson and Johnson
Sucampo
Merck
SLA Pharma
Progenics Pharmaceuticals
Synergy Pharmaceuticals
AstraZeneca
Mundipharma
Theravance
Ironwood Pharmaceuticals
Pfizer
Cosmo Pharmaceuticals
Shionogi
Abbott
Nektar Therapeutics
Bayer
Boehringer Ingelheim
Takeda Pharmaceutical
GlaxoSmithKline
In Chapter 5 and Chapter 7.3, based on types, the Opioid-Induced Constipation market from 2017 to 2027 is primarily split into:
Oral
Parenteral
In Chapter 6 and Chapter 7.4, based on applications, the Opioid-Induced Constipation market from 2017 to 2027 covers:
Drugstore
Hospital
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Opioid-Induced Constipation market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Opioid-Induced Constipation Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Opioid-Induced Constipation market are covered in Chapter 9:
Daiichi Sankyo
C.B. Fleet
Daewoong
Valeant Pharmaceuticals International
Johnson and Johnson
Sucampo
Merck
SLA Pharma
Progenics Pharmaceuticals
Synergy Pharmaceuticals
AstraZeneca
Mundipharma
Theravance
Ironwood Pharmaceuticals
Pfizer
Cosmo Pharmaceuticals
Shionogi
Abbott
Nektar Therapeutics
Bayer
Boehringer Ingelheim
Takeda Pharmaceutical
GlaxoSmithKline
In Chapter 5 and Chapter 7.3, based on types, the Opioid-Induced Constipation market from 2017 to 2027 is primarily split into:
Oral
Parenteral
In Chapter 6 and Chapter 7.4, based on applications, the Opioid-Induced Constipation market from 2017 to 2027 covers:
Drugstore
Hospital
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Opioid-Induced Constipation market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Opioid-Induced Constipation Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 OPIOID-INDUCED CONSTIPATION MARKET OVERVIEW
1.1 Product Overview and Scope of Opioid-Induced Constipation Market
1.2 Opioid-Induced Constipation Market Segment by Type
1.2.1 Global Opioid-Induced Constipation Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Opioid-Induced Constipation Market Segment by Application
1.3.1 Opioid-Induced Constipation Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Opioid-Induced Constipation Market, Region Wise (2017-2027)
1.4.1 Global Opioid-Induced Constipation Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.3 Europe Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.4 China Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.5 Japan Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.6 India Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.8 Latin America Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.5 Global Market Size of Opioid-Induced Constipation (2017-2027)
1.5.1 Global Opioid-Induced Constipation Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Opioid-Induced Constipation Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Opioid-Induced Constipation Market
2 INDUSTRY OUTLOOK
2.1 Opioid-Induced Constipation Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Opioid-Induced Constipation Market Drivers Analysis
2.4 Opioid-Induced Constipation Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Opioid-Induced Constipation Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Opioid-Induced Constipation Industry Development
3 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET LANDSCAPE BY PLAYER
3.1 Global Opioid-Induced Constipation Sales Volume and Share by Player (2017-2022)
3.2 Global Opioid-Induced Constipation Revenue and Market Share by Player (2017-2022)
3.3 Global Opioid-Induced Constipation Average Price by Player (2017-2022)
3.4 Global Opioid-Induced Constipation Gross Margin by Player (2017-2022)
3.5 Opioid-Induced Constipation Market Competitive Situation and Trends
3.5.1 Opioid-Induced Constipation Market Concentration Rate
3.5.2 Opioid-Induced Constipation Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL OPIOID-INDUCED CONSTIPATION SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Opioid-Induced Constipation Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Opioid-Induced Constipation Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Opioid-Induced Constipation Market Under COVID-19
4.5 Europe Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Opioid-Induced Constipation Market Under COVID-19
4.6 China Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Opioid-Induced Constipation Market Under COVID-19
4.7 Japan Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Opioid-Induced Constipation Market Under COVID-19
4.8 India Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Opioid-Induced Constipation Market Under COVID-19
4.9 Southeast Asia Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Opioid-Induced Constipation Market Under COVID-19
4.10 Latin America Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Opioid-Induced Constipation Market Under COVID-19
4.11 Middle East and Africa Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Opioid-Induced Constipation Market Under COVID-19
5 GLOBAL OPIOID-INDUCED CONSTIPATION SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Opioid-Induced Constipation Sales Volume and Market Share by Type (2017-2022)
5.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2017-2022)
5.3 Global Opioid-Induced Constipation Price by Type (2017-2022)
5.4 Global Opioid-Induced Constipation Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Opioid-Induced Constipation Sales Volume, Revenue and Growth Rate of Oral (2017-2022)
5.4.2 Global Opioid-Induced Constipation Sales Volume, Revenue and Growth Rate of Parenteral (2017-2022)
6 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET ANALYSIS BY APPLICATION
6.1 Global Opioid-Induced Constipation Consumption and Market Share by Application (2017-2022)
6.2 Global Opioid-Induced Constipation Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Opioid-Induced Constipation Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Opioid-Induced Constipation Consumption and Growth Rate of Drugstore (2017-2022)
6.3.2 Global Opioid-Induced Constipation Consumption and Growth Rate of Hospital (2017-2022)
6.3.3 Global Opioid-Induced Constipation Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET FORECAST (2022-2027)
7.1 Global Opioid-Induced Constipation Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Opioid-Induced Constipation Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Opioid-Induced Constipation Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Opioid-Induced Constipation Price and Trend Forecast (2022-2027)
7.2 Global Opioid-Induced Constipation Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Opioid-Induced Constipation Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Opioid-Induced Constipation Revenue and Growth Rate of Oral (2022-2027)
7.3.2 Global Opioid-Induced Constipation Revenue and Growth Rate of Parenteral (2022-2027)
7.4 Global Opioid-Induced Constipation Consumption Forecast by Application (2022-2027)
7.4.1 Global Opioid-Induced Constipation Consumption Value and Growth Rate of Drugstore(2022-2027)
7.4.2 Global Opioid-Induced Constipation Consumption Value and Growth Rate of Hospital(2022-2027)
7.4.3 Global Opioid-Induced Constipation Consumption Value and Growth Rate of Others(2022-2027)
7.5 Opioid-Induced Constipation Market Forecast Under COVID-19
8 OPIOID-INDUCED CONSTIPATION MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Opioid-Induced Constipation Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Opioid-Induced Constipation Analysis
8.6 Major Downstream Buyers of Opioid-Induced Constipation Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Opioid-Induced Constipation Industry
9 PLAYERS PROFILES
9.1 Daiichi Sankyo
9.1.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.1.3 Daiichi Sankyo Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 C.B. Fleet
9.2.1 C.B. Fleet Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.2.3 C.B. Fleet Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Daewoong
9.3.1 Daewoong Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.3.3 Daewoong Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Valeant Pharmaceuticals International
9.4.1 Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.4.3 Valeant Pharmaceuticals International Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Johnson and Johnson
9.5.1 Johnson and Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.5.3 Johnson and Johnson Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Sucampo
9.6.1 Sucampo Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.6.3 Sucampo Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Merck
9.7.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.7.3 Merck Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 SLA Pharma
9.8.1 SLA Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.8.3 SLA Pharma Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Progenics Pharmaceuticals
9.9.1 Progenics Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.9.3 Progenics Pharmaceuticals Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Synergy Pharmaceuticals
9.10.1 Synergy Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.10.3 Synergy Pharmaceuticals Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 AstraZeneca
9.11.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.11.3 AstraZeneca Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Mundipharma
9.12.1 Mundipharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.12.3 Mundipharma Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Theravance
9.13.1 Theravance Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.13.3 Theravance Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Ironwood Pharmaceuticals
9.14.1 Ironwood Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.14.3 Ironwood Pharmaceuticals Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Pfizer
9.15.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.15.3 Pfizer Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Cosmo Pharmaceuticals
9.16.1 Cosmo Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.16.3 Cosmo Pharmaceuticals Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Shionogi
9.17.1 Shionogi Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.17.3 Shionogi Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Abbott
9.18.1 Abbott Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.18.3 Abbott Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Nektar Therapeutics
9.19.1 Nektar Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.19.3 Nektar Therapeutics Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Bayer
9.20.1 Bayer Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.20.3 Bayer Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Boehringer Ingelheim
9.21.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.21.3 Boehringer Ingelheim Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
9.22 Takeda Pharmaceutical
9.22.1 Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.22.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.22.3 Takeda Pharmaceutical Market Performance (2017-2022)
9.22.4 Recent Development
9.22.5 SWOT Analysis
9.23 GlaxoSmithKline
9.23.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.23.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.23.3 GlaxoSmithKline Market Performance (2017-2022)
9.23.4 Recent Development
9.23.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Opioid-Induced Constipation Market
1.2 Opioid-Induced Constipation Market Segment by Type
1.2.1 Global Opioid-Induced Constipation Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Opioid-Induced Constipation Market Segment by Application
1.3.1 Opioid-Induced Constipation Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Opioid-Induced Constipation Market, Region Wise (2017-2027)
1.4.1 Global Opioid-Induced Constipation Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.3 Europe Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.4 China Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.5 Japan Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.6 India Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.8 Latin America Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Opioid-Induced Constipation Market Status and Prospect (2017-2027)
1.5 Global Market Size of Opioid-Induced Constipation (2017-2027)
1.5.1 Global Opioid-Induced Constipation Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Opioid-Induced Constipation Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Opioid-Induced Constipation Market
2 INDUSTRY OUTLOOK
2.1 Opioid-Induced Constipation Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Opioid-Induced Constipation Market Drivers Analysis
2.4 Opioid-Induced Constipation Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Opioid-Induced Constipation Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Opioid-Induced Constipation Industry Development
3 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET LANDSCAPE BY PLAYER
3.1 Global Opioid-Induced Constipation Sales Volume and Share by Player (2017-2022)
3.2 Global Opioid-Induced Constipation Revenue and Market Share by Player (2017-2022)
3.3 Global Opioid-Induced Constipation Average Price by Player (2017-2022)
3.4 Global Opioid-Induced Constipation Gross Margin by Player (2017-2022)
3.5 Opioid-Induced Constipation Market Competitive Situation and Trends
3.5.1 Opioid-Induced Constipation Market Concentration Rate
3.5.2 Opioid-Induced Constipation Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL OPIOID-INDUCED CONSTIPATION SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Opioid-Induced Constipation Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Opioid-Induced Constipation Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Opioid-Induced Constipation Market Under COVID-19
4.5 Europe Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Opioid-Induced Constipation Market Under COVID-19
4.6 China Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Opioid-Induced Constipation Market Under COVID-19
4.7 Japan Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Opioid-Induced Constipation Market Under COVID-19
4.8 India Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Opioid-Induced Constipation Market Under COVID-19
4.9 Southeast Asia Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Opioid-Induced Constipation Market Under COVID-19
4.10 Latin America Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Opioid-Induced Constipation Market Under COVID-19
4.11 Middle East and Africa Opioid-Induced Constipation Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Opioid-Induced Constipation Market Under COVID-19
5 GLOBAL OPIOID-INDUCED CONSTIPATION SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Opioid-Induced Constipation Sales Volume and Market Share by Type (2017-2022)
5.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2017-2022)
5.3 Global Opioid-Induced Constipation Price by Type (2017-2022)
5.4 Global Opioid-Induced Constipation Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Opioid-Induced Constipation Sales Volume, Revenue and Growth Rate of Oral (2017-2022)
5.4.2 Global Opioid-Induced Constipation Sales Volume, Revenue and Growth Rate of Parenteral (2017-2022)
6 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET ANALYSIS BY APPLICATION
6.1 Global Opioid-Induced Constipation Consumption and Market Share by Application (2017-2022)
6.2 Global Opioid-Induced Constipation Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Opioid-Induced Constipation Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Opioid-Induced Constipation Consumption and Growth Rate of Drugstore (2017-2022)
6.3.2 Global Opioid-Induced Constipation Consumption and Growth Rate of Hospital (2017-2022)
6.3.3 Global Opioid-Induced Constipation Consumption and Growth Rate of Others (2017-2022)
7 GLOBAL OPIOID-INDUCED CONSTIPATION MARKET FORECAST (2022-2027)
7.1 Global Opioid-Induced Constipation Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Opioid-Induced Constipation Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Opioid-Induced Constipation Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Opioid-Induced Constipation Price and Trend Forecast (2022-2027)
7.2 Global Opioid-Induced Constipation Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Opioid-Induced Constipation Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Opioid-Induced Constipation Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Opioid-Induced Constipation Revenue and Growth Rate of Oral (2022-2027)
7.3.2 Global Opioid-Induced Constipation Revenue and Growth Rate of Parenteral (2022-2027)
7.4 Global Opioid-Induced Constipation Consumption Forecast by Application (2022-2027)
7.4.1 Global Opioid-Induced Constipation Consumption Value and Growth Rate of Drugstore(2022-2027)
7.4.2 Global Opioid-Induced Constipation Consumption Value and Growth Rate of Hospital(2022-2027)
7.4.3 Global Opioid-Induced Constipation Consumption Value and Growth Rate of Others(2022-2027)
7.5 Opioid-Induced Constipation Market Forecast Under COVID-19
8 OPIOID-INDUCED CONSTIPATION MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Opioid-Induced Constipation Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Opioid-Induced Constipation Analysis
8.6 Major Downstream Buyers of Opioid-Induced Constipation Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Opioid-Induced Constipation Industry
9 PLAYERS PROFILES
9.1 Daiichi Sankyo
9.1.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.1.3 Daiichi Sankyo Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 C.B. Fleet
9.2.1 C.B. Fleet Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.2.3 C.B. Fleet Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Daewoong
9.3.1 Daewoong Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.3.3 Daewoong Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Valeant Pharmaceuticals International
9.4.1 Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.4.3 Valeant Pharmaceuticals International Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Johnson and Johnson
9.5.1 Johnson and Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.5.3 Johnson and Johnson Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Sucampo
9.6.1 Sucampo Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.6.3 Sucampo Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Merck
9.7.1 Merck Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.7.3 Merck Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 SLA Pharma
9.8.1 SLA Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.8.3 SLA Pharma Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Progenics Pharmaceuticals
9.9.1 Progenics Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.9.3 Progenics Pharmaceuticals Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Synergy Pharmaceuticals
9.10.1 Synergy Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.10.3 Synergy Pharmaceuticals Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 AstraZeneca
9.11.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.11.3 AstraZeneca Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Mundipharma
9.12.1 Mundipharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.12.3 Mundipharma Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Theravance
9.13.1 Theravance Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.13.3 Theravance Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Ironwood Pharmaceuticals
9.14.1 Ironwood Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.14.3 Ironwood Pharmaceuticals Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Pfizer
9.15.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.15.3 Pfizer Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Cosmo Pharmaceuticals
9.16.1 Cosmo Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.16.3 Cosmo Pharmaceuticals Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Shionogi
9.17.1 Shionogi Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.17.3 Shionogi Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Abbott
9.18.1 Abbott Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.18.3 Abbott Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Nektar Therapeutics
9.19.1 Nektar Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.19.3 Nektar Therapeutics Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Bayer
9.20.1 Bayer Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.20.3 Bayer Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Boehringer Ingelheim
9.21.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.21.3 Boehringer Ingelheim Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
9.22 Takeda Pharmaceutical
9.22.1 Takeda Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.22.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.22.3 Takeda Pharmaceutical Market Performance (2017-2022)
9.22.4 Recent Development
9.22.5 SWOT Analysis
9.23 GlaxoSmithKline
9.23.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.23.2 Opioid-Induced Constipation Product Profiles, Application and Specification
9.23.3 GlaxoSmithKline Market Performance (2017-2022)
9.23.4 Recent Development
9.23.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Opioid-Induced Constipation Product Picture
Table Global Opioid-Induced Constipation Market Sales Volume and CAGR (%) Comparison by Type
Table Opioid-Induced Constipation Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Opioid-Induced Constipation Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Opioid-Induced Constipation Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Opioid-Induced Constipation Industry Development
Table Global Opioid-Induced Constipation Sales Volume by Player (2017-2022)
Table Global Opioid-Induced Constipation Sales Volume Share by Player (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume Share by Player in 2021
Table Opioid-Induced Constipation Revenue (Million USD) by Player (2017-2022)
Table Opioid-Induced Constipation Revenue Market Share by Player (2017-2022)
Table Opioid-Induced Constipation Price by Player (2017-2022)
Table Opioid-Induced Constipation Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Opioid-Induced Constipation Sales Volume, Region Wise (2017-2022)
Table Global Opioid-Induced Constipation Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume Market Share, Region Wise in 2021
Table Global Opioid-Induced Constipation Revenue (Million USD), Region Wise (2017-2022)
Table Global Opioid-Induced Constipation Revenue Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation Revenue Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation Revenue Market Share, Region Wise in 2021
Table Global Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Opioid-Induced Constipation Sales Volume by Type (2017-2022)
Table Global Opioid-Induced Constipation Sales Volume Market Share by Type (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume Market Share by Type in 2021
Table Global Opioid-Induced Constipation Revenue (Million USD) by Type (2017-2022)
Table Global Opioid-Induced Constipation Revenue Market Share by Type (2017-2022)
Figure Global Opioid-Induced Constipation Revenue Market Share by Type in 2021
Table Opioid-Induced Constipation Price by Type (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume and Growth Rate of Oral (2017-2022)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Oral (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume and Growth Rate of Parenteral (2017-2022)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Parenteral (2017-2022)
Table Global Opioid-Induced Constipation Consumption by Application (2017-2022)
Table Global Opioid-Induced Constipation Consumption Market Share by Application (2017-2022)
Table Global Opioid-Induced Constipation Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Opioid-Induced Constipation Consumption Revenue Market Share by Application (2017-2022)
Table Global Opioid-Induced Constipation Consumption and Growth Rate of Drugstore (2017-2022)
Table Global Opioid-Induced Constipation Consumption and Growth Rate of Hospital (2017-2022)
Table Global Opioid-Induced Constipation Consumption and Growth Rate of Others (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Opioid-Induced Constipation Price and Trend Forecast (2022-2027)
Figure USA Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Opioid-Induced Constipation Market Sales Volume Forecast, by Type
Table Global Opioid-Induced Constipation Sales Volume Market Share Forecast, by Type
Table Global Opioid-Induced Constipation Market Revenue (Million USD) Forecast, by Type
Table Global Opioid-Induced Constipation Revenue Market Share Forecast, by Type
Table Global Opioid-Induced Constipation Price Forecast, by Type
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Parenteral (2022-2027)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Parenteral (2022-2027)
Table Global Opioid-Induced Constipation Market Consumption Forecast, by Application
Table Global Opioid-Induced Constipation Consumption Market Share Forecast, by Application
Table Global Opioid-Induced Constipation Market Revenue (Million USD) Forecast, by Application
Table Global Opioid-Induced Constipation Revenue Market Share Forecast, by Application
Figure Global Opioid-Induced Constipation Consumption Value (Million USD) and Growth Rate of Drugstore (2022-2027)
Figure Global Opioid-Induced Constipation Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Opioid-Induced Constipation Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Opioid-Induced Constipation Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Daiichi Sankyo Profile
Table Daiichi Sankyo Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daiichi Sankyo Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Daiichi Sankyo Revenue (Million USD) Market Share 2017-2022
Table C.B. Fleet Profile
Table C.B. Fleet Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure C.B. Fleet Opioid-Induced Constipation Sales Volume and Growth Rate
Figure C.B. Fleet Revenue (Million USD) Market Share 2017-2022
Table Daewoong Profile
Table Daewoong Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daewoong Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Daewoong Revenue (Million USD) Market Share 2017-2022
Table Valeant Pharmaceuticals International Profile
Table Valeant Pharmaceuticals International Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Valeant Pharmaceuticals International Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Valeant Pharmaceuticals International Revenue (Million USD) Market Share 2017-2022
Table Johnson and Johnson Profile
Table Johnson and Johnson Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson and Johnson Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Johnson and Johnson Revenue (Million USD) Market Share 2017-2022
Table Sucampo Profile
Table Sucampo Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sucampo Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Sucampo Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table SLA Pharma Profile
Table SLA Pharma Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure SLA Pharma Opioid-Induced Constipation Sales Volume and Growth Rate
Figure SLA Pharma Revenue (Million USD) Market Share 2017-2022
Table Progenics Pharmaceuticals Profile
Table Progenics Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Progenics Pharmaceuticals Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Progenics Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Synergy Pharmaceuticals Profile
Table Synergy Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Synergy Pharmaceuticals Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Synergy Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Profile
Table AstraZeneca Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Opioid-Induced Constipation Sales Volume and Growth Rate
Figure AstraZeneca Revenue (Million USD) Market Share 2017-2022
Table Mundipharma Profile
Table Mundipharma Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mundipharma Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Mundipharma Revenue (Million USD) Market Share 2017-2022
Table Theravance Profile
Table Theravance Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Theravance Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Theravance Revenue (Million USD) Market Share 2017-2022
Table Ironwood Pharmaceuticals Profile
Table Ironwood Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ironwood Pharmaceuticals Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Ironwood Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Cosmo Pharmaceuticals Profile
Table Cosmo Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cosmo Pharmaceuticals Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Cosmo Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Shionogi Profile
Table Shionogi Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shionogi Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Shionogi Revenue (Million USD) Market Share 2017-2022
Table Abbott Profile
Table Abbott Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Abbott Revenue (Million USD) Market Share 2017-2022
Table Nektar Therapeutics Profile
Table Nektar Therapeutics Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nektar Therapeutics Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Nektar Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Bayer Profile
Table Bayer Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Bayer Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Takeda Pharmaceutical Profile
Table Takeda Pharmaceutical Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Pharmaceutical Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Takeda Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Opioid-Induced Constipation Sales Volume and Growth Rate
Figure GlaxoSmithKline Revenue (Million USD) Market Share 2017-2022
Figure Opioid-Induced Constipation Product Picture
Table Global Opioid-Induced Constipation Market Sales Volume and CAGR (%) Comparison by Type
Table Opioid-Induced Constipation Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Opioid-Induced Constipation Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Opioid-Induced Constipation Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Opioid-Induced Constipation Industry Development
Table Global Opioid-Induced Constipation Sales Volume by Player (2017-2022)
Table Global Opioid-Induced Constipation Sales Volume Share by Player (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume Share by Player in 2021
Table Opioid-Induced Constipation Revenue (Million USD) by Player (2017-2022)
Table Opioid-Induced Constipation Revenue Market Share by Player (2017-2022)
Table Opioid-Induced Constipation Price by Player (2017-2022)
Table Opioid-Induced Constipation Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Opioid-Induced Constipation Sales Volume, Region Wise (2017-2022)
Table Global Opioid-Induced Constipation Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume Market Share, Region Wise in 2021
Table Global Opioid-Induced Constipation Revenue (Million USD), Region Wise (2017-2022)
Table Global Opioid-Induced Constipation Revenue Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation Revenue Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation Revenue Market Share, Region Wise in 2021
Table Global Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Opioid-Induced Constipation Sales Volume by Type (2017-2022)
Table Global Opioid-Induced Constipation Sales Volume Market Share by Type (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume Market Share by Type in 2021
Table Global Opioid-Induced Constipation Revenue (Million USD) by Type (2017-2022)
Table Global Opioid-Induced Constipation Revenue Market Share by Type (2017-2022)
Figure Global Opioid-Induced Constipation Revenue Market Share by Type in 2021
Table Opioid-Induced Constipation Price by Type (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume and Growth Rate of Oral (2017-2022)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Oral (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume and Growth Rate of Parenteral (2017-2022)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Parenteral (2017-2022)
Table Global Opioid-Induced Constipation Consumption by Application (2017-2022)
Table Global Opioid-Induced Constipation Consumption Market Share by Application (2017-2022)
Table Global Opioid-Induced Constipation Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Opioid-Induced Constipation Consumption Revenue Market Share by Application (2017-2022)
Table Global Opioid-Induced Constipation Consumption and Growth Rate of Drugstore (2017-2022)
Table Global Opioid-Induced Constipation Consumption and Growth Rate of Hospital (2017-2022)
Table Global Opioid-Induced Constipation Consumption and Growth Rate of Others (2017-2022)
Figure Global Opioid-Induced Constipation Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Opioid-Induced Constipation Price and Trend Forecast (2022-2027)
Figure USA Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Opioid-Induced Constipation Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Opioid-Induced Constipation Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Opioid-Induced Constipation Market Sales Volume Forecast, by Type
Table Global Opioid-Induced Constipation Sales Volume Market Share Forecast, by Type
Table Global Opioid-Induced Constipation Market Revenue (Million USD) Forecast, by Type
Table Global Opioid-Induced Constipation Revenue Market Share Forecast, by Type
Table Global Opioid-Induced Constipation Price Forecast, by Type
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Oral (2022-2027)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Parenteral (2022-2027)
Figure Global Opioid-Induced Constipation Revenue (Million USD) and Growth Rate of Parenteral (2022-2027)
Table Global Opioid-Induced Constipation Market Consumption Forecast, by Application
Table Global Opioid-Induced Constipation Consumption Market Share Forecast, by Application
Table Global Opioid-Induced Constipation Market Revenue (Million USD) Forecast, by Application
Table Global Opioid-Induced Constipation Revenue Market Share Forecast, by Application
Figure Global Opioid-Induced Constipation Consumption Value (Million USD) and Growth Rate of Drugstore (2022-2027)
Figure Global Opioid-Induced Constipation Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Opioid-Induced Constipation Consumption Value (Million USD) and Growth Rate of Others (2022-2027)
Figure Opioid-Induced Constipation Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Daiichi Sankyo Profile
Table Daiichi Sankyo Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daiichi Sankyo Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Daiichi Sankyo Revenue (Million USD) Market Share 2017-2022
Table C.B. Fleet Profile
Table C.B. Fleet Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure C.B. Fleet Opioid-Induced Constipation Sales Volume and Growth Rate
Figure C.B. Fleet Revenue (Million USD) Market Share 2017-2022
Table Daewoong Profile
Table Daewoong Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Daewoong Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Daewoong Revenue (Million USD) Market Share 2017-2022
Table Valeant Pharmaceuticals International Profile
Table Valeant Pharmaceuticals International Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Valeant Pharmaceuticals International Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Valeant Pharmaceuticals International Revenue (Million USD) Market Share 2017-2022
Table Johnson and Johnson Profile
Table Johnson and Johnson Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson and Johnson Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Johnson and Johnson Revenue (Million USD) Market Share 2017-2022
Table Sucampo Profile
Table Sucampo Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sucampo Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Sucampo Revenue (Million USD) Market Share 2017-2022
Table Merck Profile
Table Merck Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Merck Revenue (Million USD) Market Share 2017-2022
Table SLA Pharma Profile
Table SLA Pharma Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure SLA Pharma Opioid-Induced Constipation Sales Volume and Growth Rate
Figure SLA Pharma Revenue (Million USD) Market Share 2017-2022
Table Progenics Pharmaceuticals Profile
Table Progenics Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Progenics Pharmaceuticals Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Progenics Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Synergy Pharmaceuticals Profile
Table Synergy Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Synergy Pharmaceuticals Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Synergy Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Profile
Table AstraZeneca Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Opioid-Induced Constipation Sales Volume and Growth Rate
Figure AstraZeneca Revenue (Million USD) Market Share 2017-2022
Table Mundipharma Profile
Table Mundipharma Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mundipharma Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Mundipharma Revenue (Million USD) Market Share 2017-2022
Table Theravance Profile
Table Theravance Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Theravance Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Theravance Revenue (Million USD) Market Share 2017-2022
Table Ironwood Pharmaceuticals Profile
Table Ironwood Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ironwood Pharmaceuticals Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Ironwood Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Cosmo Pharmaceuticals Profile
Table Cosmo Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cosmo Pharmaceuticals Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Cosmo Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Shionogi Profile
Table Shionogi Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shionogi Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Shionogi Revenue (Million USD) Market Share 2017-2022
Table Abbott Profile
Table Abbott Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Abbott Revenue (Million USD) Market Share 2017-2022
Table Nektar Therapeutics Profile
Table Nektar Therapeutics Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nektar Therapeutics Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Nektar Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Bayer Profile
Table Bayer Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bayer Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Bayer Revenue (Million USD) Market Share 2017-2022
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Boehringer Ingelheim Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Boehringer Ingelheim Revenue (Million USD) Market Share 2017-2022
Table Takeda Pharmaceutical Profile
Table Takeda Pharmaceutical Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Pharmaceutical Opioid-Induced Constipation Sales Volume and Growth Rate
Figure Takeda Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Opioid-Induced Constipation Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Opioid-Induced Constipation Sales Volume and Growth Rate
Figure GlaxoSmithKline Revenue (Million USD) Market Share 2017-2022
